Cryoactivation of inactive renin in human plasma. 1979

A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai

The mechanism of the increase in renin activity in human plasma which had been kept -5 degrees C for 4 days (cryoactivation) was investigated. From the results of clinical studies, it is likely that the controling mechanism of inactive renin has something in common with that of active renin. The experimental data showed that the increase in renin activity of human plasma by cryoactivation was closely correlated to the increase obtained by incubation with trypsin (r = 0.88, p less than 0.001, n = 10). Soybean trypsin inhibitor, aprotinin and di-isopropylfluorophosphate (DFP) inhibited cryoactivation, indicating that the cryoactivation is due to the action of a trypsin-like serine enzyme. Trypsin which had no effect on plasma renin activity in the presence of the same amount of soybean trypsin inhibitor at 37 degrees C, activated the renin activity during cold incubation, suggesting that the dissociation of the trypsin-inhibitor complex may have taken place at a low temperature. Endogenous trypsin inhibitor is also likely to lose its affinity to endogenous trypsin-like enzyme at a low temperature.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D014361 Trypsin Inhibitors Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. Trypsin Inhibitor,Inhibitor, Trypsin,Inhibitors, Trypsin

Related Publications

A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
October 1991, Journal of the Formosan Medical Association = Taiwan yi zhi,
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
May 1978, Archives internationales de physiologie et de biochimie,
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
July 1979, Clinica chimica acta; international journal of clinical chemistry,
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
May 1979, Klinische Wochenschrift,
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
January 1982, Laboratornoe delo,
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
September 1976, Lancet (London, England),
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
December 1976, Lancet (London, England),
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
October 1976, Lancet (London, England),
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
October 1976, Lancet (London, England),
A Hara, and M Matsunaga, and J Yamamoto, and K Morimoto, and H Nagai, and C H Pak, and K Kanatsu, and K Ogino, and C Kawai
May 1977, Circulation research,
Copied contents to your clipboard!